| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |